Anthias Biopharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 713.22%
- Profit Growth -101.85%
- Ebitda -134.29%
- Net Worth -218.28%
- Total Assets -5.92%
About Anthias Biopharma
Anthias Biopharma Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 November 2018 (Six years and two months 15 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shalini Agarwal and Shreyasi Agrawal serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2018PTC317397
-
Company No.
317397
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Nov 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Anthias Biopharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shalini Agarwal
|
Director | 26-Nov-2018 | Current |
|
Shreyasi Agrawal
|
Director | 26-Nov-2018 | Current |
Financial Performance of Anthias Biopharma.
Anthias Biopharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 713.22% increase. The company also saw a substantial fall in profitability, with a 101.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 218.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anthias Biopharma?
In 2021, Anthias Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aaja Residency Private LimitedShalini Agarwal and Shreyasi Agrawal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anthias Biopharma?
Unlock and access historical data on people associated with Anthias Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anthias Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anthias Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.